Bli medlem
Bli medlem

Du är här


Saniona: Redeye: Saniona - PWS is (ultra-) orphan!

In this update, we will do a deep-dive of the two programs that have
advanced in the last couple of months, i.e., the Ataxia program and
Tesomet within eating disorders. The Ataxia program still represents
a small share of our total value whereas we see the Tesomet program
within eating disorders to have the largest potential for Saniona.

Read more in the Research Update by Anders Hedlund:

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment


Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.